- Home
- RBOT vs HLVX Comparison
RBOT vs HLVX Comparison
Compare RBOT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- HLVX
- Stock Information
- Founded
- RBOT 2014
- HLVX 2020
- Country
- RBOT United States
- HLVX United States
- Employees
- RBOT 131
- HLVX N/A
- Industry
- RBOT Medical Specialities
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- HLVX Health Care
- Exchange
- RBOT Nasdaq
- HLVX Nasdaq
- Market Cap
- RBOT 45.8M
- HLVX 83.7M
- IPO Year
- RBOT N/A
- HLVX 2022
- Fundamental
- Price
- RBOT $8.99
- HLVX $2.12
- Analyst Decision
- RBOT Hold
- HLVX Hold
- Analyst Count
- RBOT 2
- HLVX 5
- Target Price
- RBOT $9.25
- HLVX $2.33
- AVG Volume (30 Days)
- RBOT 11.4K
- HLVX 432.0K
- Earning Date
- RBOT 08-11-2025
- HLVX 08-07-2025
- Dividend Yield
- RBOT N/A
- HLVX N/A
- EPS Growth
- RBOT N/A
- HLVX N/A
- EPS
- RBOT N/A
- HLVX N/A
- Revenue
- RBOT N/A
- HLVX N/A
- Revenue This Year
- RBOT N/A
- HLVX N/A
- Revenue Next Year
- RBOT N/A
- HLVX N/A
- P/E Ratio
- RBOT N/A
- HLVX N/A
- Revenue Growth
- RBOT N/A
- HLVX N/A
- 52 Week Low
- RBOT $4.27
- HLVX $1.34
- 52 Week High
- RBOT $19.00
- HLVX $2.15
- Technical
- Relative Strength Index (RSI)
- RBOT 59.44
- HLVX 63.08
- Support Level
- RBOT $7.21
- HLVX $1.98
- Resistance Level
- RBOT $8.30
- HLVX $2.12
- Average True Range (ATR)
- RBOT 0.43
- HLVX 0.08
- MACD
- RBOT 0.05
- HLVX 0.01
- Stochastic Oscillator
- RBOT 99.58
- HLVX 89.66
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.